Top Companies in the Near Infrared Imaging

The global near-infrared imaging market is projected to reach USD 2.07 billion by 2030 from USD 1.25 billion in 2025, at a CAGR of 10.6%. The growth in this market is driven by increasing investments, supportive funds & grants for research on pharmaceuticals, the growing significance of biomolecular analysis, and the rising demand for chromatography solutions in applied industries.

The near-infrared imaging market is moderately competitive, with established companies and emerging players vying for market share. As of 2024, the key companies operating in the global near-infrared imaging market include Stryker (US), Carl Zeiss Meditec AG (Germany), PerkinElmer, Inc. (US), Olympus Corporation (Japan), and Leica Microsystems (Germany). In the past four years, leading near-infrared imaging market companies have implemented key strategies, including launches, forming agreements, and pursuing expansions. These organic and inorganic strategies have allowed the market players to expand themselves across geographies by offering NIR systems.

To know about the assumptions considered for the study download the pdf brochure

• In March 2024, Stryker (US) launched its 1788 Advanced Fluorescence Imaging Platform, which has AI-enabled fluorescence imaging capabilities, designed for real-time visualization of tumor tissue and perfusion during minimally invasive surgeries.
• In September 2023, Hamamatsu Photonics K.K. (Japan) launched the PDE-GEN3, a surgical-grade NIR fluorescence imaging system designed to enhance real-time intraoperative differentiation of tissue. It utilizes dual CMOS sensors to capture visible and fluorescent images simultaneously, enabling real-time mode switching and the overlay of pseudo-color ICG fluorescence on color or monochrome visuals.

Stryker (US) has a strong background and expertise in the field of medical imaging. The company has extensive knowledge and experience in developing and manufacturing advanced imaging systems, which can be leveraged to produce near-infrared imaging devices. Stryker is also known for its commitment to technological innovation. The company invests in R&D to stay at the forefront of medical device advancements, develops cutting-edge technologies, and integrates them into its near-infrared imaging systems, ensuring the company is equipped with the latest features and capabilities. Stryker acquired MOLLI Surgical Inc. in July 2024, to add to its portfolio in near-infrared imaging. This acquisition combines the existing near-infrared imaging solutions of Stryker with surgical solutions of MOLLI Surgical in breast cancer care to strengthen its intraoperative imaging capabilities.

Leica Microsystems (US) is one of the leading providers of advanced surgical visualization products. The company was the first to receive the FDA 510(k) clearance for a microscope for intra-operative angiography (FL800) and the first company offering a surgical microscope to integrate the three types of fluorescence capabilities (FL400, FL560, FL800) in a single product, TriFluoro. Leica constantly invests in R&D and partners with neurosurgeons to bring new, technologically advanced products. Additionally, Leica has sales and service organizations in 20 countries, with an international network of distribution partners in over 100 countries. Leica Microsystems released Mateo FL, an AI-powered digital fluorescence microscope, its advanced NIR fluorescence imaging platform, which integrates machine learning for improved tissue identification during surgery. It utilizes dual CMOS sensors to capture visible and fluorescent images simultaneously, enabling real-time mode switching and the overlay of pseudo-color ICG fluorescence on color or monochrome visuals.

Market Ranking:

The near-infrared (NIR) imaging market is highly consolidated, with five key players collectively accounting for 70–80% of the total market share. Stryker stands out with its advanced NIR fluorescence imaging systems, which are widely used in surgical visualization. Carl Zeiss maintains a robust presence due to its expertise in high-precision optics and integrated surgical solutions. PerkinElmer has strengthened its position with innovative preclinical imaging platforms, while Olympus Corporation and Leica Microsystems continue to lead through high-quality surgical microscopes with fluorescence capabilities. As the demand for real-time visualization in cancer, cardiovascular, and reconstructive surgeries rises, these players are enhancing their product offerings with multimodal imaging, improved resolution, and user-friendly interfaces. The remaining 20–30% of the market comprises emerging players and niche technology providers, contributing to ongoing innovation and regional diversification. Market competitiveness is driven by advancements in sensor technologies, increasing surgical volumes, integration with robotic systems, and growing clinical adoption of fluorescence-guided procedures. Market competition is driven by advancements in optical imaging technologies, rising demand for real-time intraoperative visualization, increasing adoption in oncology and surgical diagnostics, evolving clinical imaging standards, expansion of fluorescence-guided procedures, and the rapid integration of AI-enhanced image analysis tools in emerging healthcare settings.

Related Reports:

Near infrared imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, Cardio, GI, OBGYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com